Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-02-22 @ 9:29 AM
Study NCT ID:
NCT02685020
Status:
COMPLETED
Last Update Posted:
2025-02-03
First Post:
2016-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
Sponsor:
Janssen Vaccines & Prevention B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-12
First Submit QC Date:
None
Study First Post Date:
2016-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-31
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL